A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients

Clinical trial NCT04237805 · UNKNOWN

Trial details

NCT number: NCT04237805
Sponsor: Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Cancer Advanced Solid Tumor Lung Cancer, Nonsmall Cell

Start date: 2016-11-14
Primary completion: 2022-12-31
Enrollment: 280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.